These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 816717

  • 1. [Factor VIII inhibitor in a patient with mild haemophilia A (author's transl)].
    Gastaldi G, Avanzi G, Saccon C, Galletti A.
    Haematologica; 1975 Dec; 60(4):477-84. PubMed ID: 816717
    [No Abstract] [Full Text] [Related]

  • 2. [Inhibitors (antibodies) directed against factor VIII in hemophilia A (author's transl)].
    Beck EA.
    Ther Umsch; 1979 Apr; 36(4):326-9. PubMed ID: 377556
    [No Abstract] [Full Text] [Related]

  • 3. [Investigation and treatment of hemophilia A with inhibitor of factor VIII (author's transl)].
    Fukutake K, Fujimari M, Ukita M, Kitahara T.
    Rinsho Ketsueki; 1973 Dec; 14(0):1393-99. PubMed ID: 4807613
    [No Abstract] [Full Text] [Related]

  • 4. Inhibitor to factor VIII in mild haemophilia.
    Kesteven PJ, Holland LJ, Lawrie AS, Savidge GF.
    Thromb Haemost; 1984 Aug 31; 52(1):50-2. PubMed ID: 6437010
    [Abstract] [Full Text] [Related]

  • 5. [Determination of coagulation factor VIII inhibitors].
    Lutze G, Schlote A, Mittler U.
    Z Gesamte Inn Med; 1980 Apr 15; 35(8):330-6. PubMed ID: 6776700
    [Abstract] [Full Text] [Related]

  • 6. [Epidemiology, immunology, and methods for the detection of inhibitors in haemophilia (author's transl)].
    Ortega F, Martin Villar J, Magallon M.
    Sangre (Barc); 1978 Apr 15; 23(5B):688-98. PubMed ID: 725713
    [No Abstract] [Full Text] [Related]

  • 7. Activated ppsb in the treatment of a patient with haemophilia and antibodies to factor VIII.
    Ekert H, McVeagh P.
    Med J Aust; 1975 Oct 25; 2(17):675-7. PubMed ID: 1207551
    [Abstract] [Full Text] [Related]

  • 8. [Factor VIII-like antigen in haemophilia A and in Willebrand's disease (author's transl)].
    Blatný J, Procházka J, Bártová A, Fischerová E, Slepicka L, Skodová M.
    Cas Lek Cesk; 1975 Sep 19; 114(38):1174-6. PubMed ID: 1081010
    [No Abstract] [Full Text] [Related]

  • 9. Factor VIII antibody in a patient with mild haemophilia.
    Bovill EG, Burns SL, Golden EA.
    Br J Haematol; 1985 Oct 19; 61(2):323-8. PubMed ID: 3929830
    [Abstract] [Full Text] [Related]

  • 10. [Hepatitis-associated antigen and antibodies after multiple transfusions in children and juveniles with severe and moderately severe haemophilia (author's transl)].
    Schwartz B, Landbeck G.
    Dtsch Med Wochenschr; 1973 Oct 19; 98(43):2016-9. PubMed ID: 4744372
    [No Abstract] [Full Text] [Related]

  • 11. Acquired haemophilia: functional study of antibodies to Factor VIII.
    Allain JP, Gaillandre A, Frommel D.
    Thromb Haemost; 1981 Jun 30; 45(3):285-9. PubMed ID: 6792741
    [Abstract] [Full Text] [Related]

  • 12. A higher than expected incidence of factor VIII inhibitors in multitransfused haemophilia A patients treated with an intermediate purity pasteurized factor VIII concentrate.
    Peerlinck K, Arnout J, Gilles JG, Saint-Remy JM, Vermylen J.
    Thromb Haemost; 1993 Feb 01; 69(2):115-8. PubMed ID: 8456422
    [Abstract] [Full Text] [Related]

  • 13. Inhibitors to factor VIII in a family with mild hemophilia: molecular characterization and response to factor VIII and desmopressin.
    Santagostino E, Gringeri A, Tagliavacca L, Mannucci PM.
    Thromb Haemost; 1995 Aug 01; 74(2):619-21. PubMed ID: 8584995
    [Abstract] [Full Text] [Related]

  • 14. Inhibitor to factor VIII in mild haemophilia.
    Lowe GD, Forbes CD.
    Thromb Haemost; 1985 Feb 18; 53(1):159. PubMed ID: 3922079
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The rapid development of an IgM inhibitor of porcine factor VIII in a patient with acquired haemophilia.
    Weston Smith SG, Revell P, Lawrie AS, Holland LJ, Savidge GF.
    Br J Haematol; 1990 Jul 18; 75(3):434-6. PubMed ID: 2117466
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Molecular defect in hemophilia and von Willebrand's disease (author's transl)].
    Fukui H.
    Rinsho Byori; 1976 Apr 18; 24(4):274-8. PubMed ID: 1084430
    [No Abstract] [Full Text] [Related]

  • 19. Longitudinal analysis of factor VIII inhibitors in a previously untreated mild haemophilia A patient with an Arg593-->Cys substitution.
    van den Brink EN, Timmermans SM, Turenhout EA, Bank CM, Fijnvandraat K, Voorberg J, Peters M.
    Thromb Haemost; 1999 May 18; 81(5):723-6. PubMed ID: 10365744
    [Abstract] [Full Text] [Related]

  • 20. HLA class II genotype and factor VIII inhibitors in mild haemophilia A patients with an Arg593 to Cys mutation.
    Bril WS, MacLean PE, Kaijen PH, van den Brink EN, Lardy NM, Fijnvandraat K, Peters M, Voorberg J.
    Haemophilia; 2004 Sep 18; 10(5):509-14. PubMed ID: 15357778
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.